Stock Message Board http://investorshangout.com/search?q=GNBT&...mp;yt1=Go!
Last Updated: Sunday, October 13, 2013 04:38:57 AM
Generex Biotechnology Corp. GNBT Current Price and Quotes
Last Price 0.0305
Previous Close 0.03 Open 0.031
Daily Range 0.031 - 0.0296 52wk Range 0.07 - 0.02
Volume 865,536 Dividend N/A
Average Vol (3m) 2,351,943 Yield N/A
Generex Biotechnology Corp. GNBT
Company Verified Profile
Company Information
555 Richmond Street West
Suite 604
Toronto, ON M5V 3B1
Canada
Website: http://www.generex.com
Phone: 416-364-2551
Email: info@generex.com
Generex Biotechnology Corp. GNBT
Not Available
Generex Biotechnology Corp. GNBT
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jul 31, 2013 10-K
CIK 0001059784
Fiscal Year End 7/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Mark Fletcher CEO, President
David Brusegard COO
Stephen Fellows CFO
Todd Falls Corp. Mktg. & IR Manager
Company Directors
John P. Barratt Chairman
Mark Fletcher
Company Notes
Note=4-99 State of Incorporation Idaho changed to Delaware
Formerly=Green Mt P.S. Inc. until 1-98
Service Providers
Auditor/Accountant
MNP LLP
1055 Dunsmuir Street
Suite 2300
Vancouver, BC, V7X 1J1
Canada
Legal Counsel
Not Available
Investor Relations Firm
Not Available
Generex Biotechnology Corp. GNBT
GNBT Security Details
Share Structure
Market Value1 $16,211,521 a/o Oct 11, 2013
Shares Outstanding 531,525,287 a/o Jun 07, 2013
Float Not Available
Authorized Shares Not Available
Par Value 0.001
Shareholders
Shareholders of Record 596 a/o Oct 15, 2012
Short Selling Data
Short Interest 251 (-92.62%)
Sep 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)
Broadridge Financial Solutions, Inc.
Generex Biotechnology Corp. GNBT Financials
Period Ending Jul 31, 2012 Jul 31, 2011 Jul 31, 2010 Jul 31, 2009
Total Revenue 29 292 1,173 1,119
Cost of Revenue 11 156 812 528
Gross Profit 18 136 360 591
Operating Expenses
Research and Development 4,987 10,250 13,361 13,562
Sales, General and Admin. 5,054 14,419 16,429 13,285
Non-Recurring Items - - - -
Other - - - -
Operating Income (10,024) (24,533) (29,430) (26,256)
Income From Continuing Operations
Add'l Income/Expense Items 1,126 3,066 4,360 559
Earnings Before Interest and Tax (8,898) (21,467) (25,070) (25,698)
Interest Expense 593 209 210 20,115
Earnings Before Tax (9,490) (21,676) (25,280) (45,812)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (9,490) (21,676) (25,280) (45,812)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (9,490) (21,676) (25,280) (45,812)
Preferred Stock and Other Adjustments (377) (766) - -
Net Income Applicable to Common Shareholders (9,867) (22,442) (25,280) (45,812)
Generex Biotechnology Corp. GNBT Recent News
Oct 10, 2013 OTC Signal Daily Stock Watch - Generex (OTCBB: GNBT)
Sept 27, 2013 Generex Provides Update on Generex Oral-lyn(TM) Conference Call
Sept 12, 2013 OTC Signal Daily Stock Watch - Generex Biotechnology Corporation (OTC: GNBT)
Aug 20, 2013 Generex Announces Publication of Follow-up Studies from Phase I Trial of Novel Immunotherapeutic in Prostate Cancer Patients
Aug 13, 2013 Generex Announces Podium Presentation on Antigen Express Cancer Vaccine Strategy
Aug 12, 2013 Generex Provides Call-In Details for Conference Call with Members of the Antigen Express Scientific Advisory Board
Aug 9, 2013 OTC Daily Alert Stock Watch - Generex (OTCQB:GNBT)
Jul 23, 2013 Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board
GNBT Generex Biotechnology Corp. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=GNBT&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GNBT/quote
Stock Chart http://www.otcmarkets.com/stock/GNBT/chart
Company Info http://www.otcmarkets.com/stock/GNBT/company-info
Recent News http://www.otcmarkets.com/stock/GNBT/news
Financials http://www.otcmarkets.com/stock/GNBT/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GNBT/filings
Short Sales http://www.otcmarkets.com/stock/GNBT/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GNBT/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GNBT/research
Summary http://finance.yahoo.com/q?s=GNBT
Historical Prices http://finance.yahoo.com/q/hp?s=GNBT+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GNBT
Basic Chart http://finance.yahoo.com/q/bc?s=GNBT+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GNBT+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GNBT+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GNBT+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GNBT+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GNBT+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GNBT+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GNBT+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GNBT+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GNBT+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GNBT
Balance Sheet http://finance.yahoo.com/q/bs?s=GNBT
Cash Flow http://finance.yahoo.com/q/cf?s=GNBT+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GNBT
Market Watch http://www.marketwatch.com/investing/stock/GNBT
Bloomberg http://www.bloomberg.com/quote/GNBT:US
Morningstar http://quotes.morningstar.com/stock/s?t=GNBT
Bussinessweek http://investing.businessweek.com/research/st...icker=GNBT
Barchart http://www.barchart.com/quotes/stocks/GNBT
OTC Short Report http://otcshortreport.com/index.php?index=GNBT
Investopedia http://www.investopedia.com/markets/stocks/GNBT/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC